Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14276 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 141 of 143 pages ‹ First < 139 140 141 142 143 >
HSL2628
Miller P.
Is academic medicine for sale? (12th of 13 letters)
New England Journal of Medicine 2000 Aug 17; 343:(7):510
http://content.nejm.org/cgi/content/full/343/7/508
HSL6950
Bellin E.
Clinical investigators and the pharmaceutical industry.
N Engl J Med 2000 Aug 17; 343:(7):511
http://content.nejm.org/cgi/content/full/343/7/510
HSL6953
Dillon DC.
Is academic medicine for sale? (6th of 13 letters)
New England Journal of Medicine 2000 Aug 17; 343:(7):509
http://content.nejm.org/cgi/content/full/343/7/508
HSL6954
Firlik AD, Lowry DW.
Is academic medicine for sale?
N Engl J Med 2000 Aug 17; 343:(7):509-10
http://content.nejm.org/cgi/content/full/343/7/508
HSL6955
Hagan BM.
Is academic medicine for sale? (11th of 13 letters)
New England Journal of Medicine 2000 Aug 17; 343:(7):510
http://content.nejm.org/cgi/content/full/343/7/508
HSL6956
Jagger J.
Is academic medicine for sale?
N Engl J Med 2000 Aug 17; 343:(7):509
http://content.nejm.org/cgi/content/full/343/7/508
HSL6957
Lebowitz J.
Is academic medicine for sale?
N Engl J Med 2000 Aug 17; 343:(7):509
http://content.nejm.org/cgi/content/full/343/7/508
HSL6958
Leong GB, Silva AJ.
Is academic medicine for sale? (5th of 13 letters)
New England Journal of Medicine 2000 Aug 17; 343:(7):509
http://content.nejm.org/cgi/content/full/343/7/508
HSL20141
Toy M-A
Expert warns drug ads may make us a nation of hypochondriacs
The Age 2000 Aug 14
HSL20127
Parnell K
Conflict on direct drug promotion
Australian Doctor 2000 Aug 1127
HSL6949
McCarthy M.
Medical-education companies come under fire in USA
Lancet 2000 Aug 5; 356:494
HSL20153
Rankin P
Prescription-only medication should be advertised in the media: Yes
Medical Observer 2000 Aug 430
HSL20154
Young S
Prescription-only medication should be advertised in the media: No
Medical Observer 2000 Aug 431
HSL7911
Sellers JA.
The two faces of direct-to-consumer advertising.
Am J Health Syst Pharm 2000 Aug 1; 57:(15):1401
http://www.ajhp.org/cgi/reprint/57/15/1401
HSL7914
Thompson CA.
Medicare to use new wholesale drug prices, says Shalala
American Journal of Health System Pharmacy 2000 Aug 1; 57:1384, 1386
HSL18013
Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Edmondson AC, Bates DW.
Incidence and preventability of adverse drug events in nursing homes.
Am J Med 2000 Aug 1; 109:(2):87-94
http://linkinghub.elsevier.com/retrieve/pii/S0002-9343(00)00451-4
HSL6947
Conflicts of interest (Relations between health professionals and industry)
Prescrire International 2000 Aug; 9:(48):126
HSL6948
Chepesiuk R, Perkin RL.
Who looks at drug advertising?
Canadian Family Physician 2000 Aug; (46):
HSL7839
Carpenter D.
Bitter pills
Hospitals and Health Networks 2000 Aug; 74:48-52
HSL17263
Sleight P
Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!
Current Controlled Trials in Cardiovascular Medicine 2000 July 31; 1:(1):25-27
http://trialsjournal.com/content/1/1/25
HSL19540
Stolberg SG, Gerth J
How Companies Stall Generics and Keep Themselves Healthy
The New York Times 2000 July 23
http://www.commondreams.org/headlines/072300-03.htm
HSL2626
Montauk L.
Medical junk mail.
Lancet 2000 Jul 22; 356:(9226):344
HSL6946
Durrington PN, Chantler K.
Academia and industry.
Lancet 2000 Jul 22; 356:(9226):339
HSL19878
Milne R, Booth-Clibborn N, Oliver S.
Consumer health information needs to be rigorous, complete, and relevant
BMJ 2000 July 22; 321:(7255):240
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1118232/
HSL19539
Ross JS, Lurie P, Wolfe SM
Medical Education Services Supplies: A Threat to Physician Education. Public Citizen
Public Citizen 2000 July 19
http://www.citizen.org/hrg1530
HSL2575
Wolfe S, Lurie P, Sasich L, Barbehenn E.
Information on thiazolidinediones (1st of 2 letters)
The Lancet 2000 Jul 15; 356:254-5
HSL6945
Auwerx J.
Information on thiazolidinediones (2nd of 2 letters)
The Lancet 2000 Jul 15; 356:255
HSL16739
Wolfe SM, Lurie P, Sasich LD, Barbehenn E.
Information on thiazolidinediones.
Lancet 2000 Jul 15; 356:(9225):254-5
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(05)74507-4
HSL2603
Recker RR.
Disclosure of authors' conflicts of interest--a follow-up.
N Engl J Med 2000 Jul 13; 343:(2):146
http://content.nejm.org/cgi/content/full/343/2/146
HSL2617
Recker RR.
Disclosure of authors' conflicts of interest - A follow-up (2nd of 4 letters)
New England Journal of Medicine 2000 Jul 13; 343:(2):146
http://content.nejm.org/cgi/content/full/343/2/146
HSL2630
McMasters KM.
Disclosure of authors' conflicts of interest - A follow-up (1st of 4 letters)
New England Journal of Medicine 2000 Jul 13; 343:(2):146
http://content.nejm.org/cgi/content/full/343/2/146
HSL6943
Goldberg B.
Disclosure of authors' conflicts of interest--a follow-up.
N Engl J Med 2000 Jul 13; 343:(2):146-7
HSL6944
McMasters KM.
Disclosure of authors' conflicts of interest--a follow-up.
N Engl J Med 2000 Jul 13; 343:(2):146
HSL20102
Whelan J
Relaxing of drug ad rules likely
The Sydney Morning Herald 2000 July 5
http://newsstore.smh.com.au/apps/viewDocument.ac?page=1&sy=smh&kw=Relaxing+of+drug+ad+rules+likely&pb=all_ffx&dt=selectRange&dr=entire&so=relevance&sf=text&sf=headline&rc=10&rm=200&sp=nrm&clsPage=1&docID=news000705_0407_2939
HSL7910
Levy S.
Study finds strong consumer awareness of DTC Rx ads
Drug Topics 2000 Jul 3; 144:47
HSL19762
Mansfield P
Sickening sales pitch of the drug marketeers
The Sydney Morning Herald 2000 July 3
http://newsstore.smh.com.au/apps/viewDocument.ac?page=1&sy=smh&kw=Sickening+sales+pitch+of+the+drug&pb=smh&dt=selectRange&dr=entire&so=relevance&sf=text&sf=headline&rc=10&rm=200&sp=nrm&clsPage=1&docID=news000703_0087_8149
HSL20094
Rodger S
Pharmaceutical adverts
NZ Herald 2000 July 3
HSL229
Chew LD, O'Young TS, Hazlet TK, Bradley KA, Maynard C, Lessler DS.
A physician survey of the effect of drug sample availability on physicians' behavior.
J Gen Intern Med 2000 Jul; 15:(7):478-83
HSL7837
Brotman BA.
The price of pharmaceuticals given managed care health insurance membership.
Pharm Pract Manag Q 2000 Jul; 20:(2):16-9
HSL7915
Wechsler J.
Health plans and payers attack DTC advertising, seek objective information on medication value
Formulary 2000 Jul; 35:616-617
HSL13291
Fuan L, Miniard PW, Barone MJ.
The Facilitating Influence of Consumer Knowledge on the Effectiveness of Daily Value Reference Information
Journal of the Academy of Marketing Science 2000 Jul; 28:(3):425-35
http://jam.sagepub.com/cgi/content/abstract/28/3/425
HSL20103
Moynihan R
Drug advertising may be easier
The Australian Financial Review 2000 Jun 297
HSL20134
De Boni D
The new opiate of the people?
NZ Herald 2000 Jun 29
HSL20135
Read J
Drug adverts dishonest
NZ Herald 2000 Jun 28
HSL2590
Rubin P.
The New England Journal of Medicine - To whom is it accountable?
2000 Jun 27;
HSL20100
TV drug adverts criticised
The Press 2000 Jun 27
HSL2017
Seaman B.
The Pill and I: 40 Years On, the Relationship Remains Wary
The New York Times 2000 Jun 25
HSL15084
McCormack J, Greenhalgh T.
Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data. United Kingdom prospective diabetes study.
BMJ. 2000 Jun 24; 320:(7251):1720-3
http://www.bmj.com/cgi/content/full/320/7251/1720?view=long&pmid=10864554
HSL20093
Rodger S
Pills for ills
NZ Listener 2000 Jun 24
HSL20099
De Boni D
Drug firms hand out placebo to ad critics
2000 Jun 24
HSL20096
Mold F
Caution urged over drug advertising
MediaSearch 2000 Jun 23
HSL20098
Simpson M
Report on controversial drug stand attracts global interest
The National Business Review 2000 Jun 23
HSL20136
Moynihan R
NZ to get tough on drug ads
The Australian Financial Review 2000 Jun 23
HSL2576
Wilmshurst P.
Academia and industry (1st of 2 letters)
The Lancet 2000 Jun 22; 356:338-339
HSL18015
Angell M.
The pharmaceutical industry--to whom is it accountable?
N Engl J Med 2000 Jun 22; 342:(25):1902-4
http://content.nejm.org/cgi/content/extract/342/25/1902
HSL20092
Pill scare 'shows dangers' of ads
New Zealand Press Association 2000 Jun 22
HSL20095
Pill scare shows advertising risk, says Pharmac
The Evening Post 2000 Jun 22
HSL20101
Drug promotion risks highlighted
West Coast Times 2000 Jun 22
HSL20111
Moynihan R
Glaxo defends flu campaign
The Australian Financial Review 2000 Jun 20
HSL2605
O'Hare N.
Pill pushers
Listener 2000 Jun 1719-23
HSL7934
Texas fight over drug product selection ends
American Journal of Health System Pharmacy 2000 Jun 15; 57:1117
HSL7945
Chisholm MA, Reinhardt BO, Vollenweider LJ, Kendrick BD, DiPiro JT.
Medication assistance programs for uninsured and indigent patients.
Am J Health Syst Pharm 2000 Jun 15; 57:(12):1131-6
http://www.ajhp.org/cgi/reprint/57/12/1131
HSL207
Tallon D, Chard J, Dieppe P.
Relation between agendas of the research community and the research consumer.
Lancet 2000 Jun 10; 355:(9220):2037-40
http://linkinghub.elsevier.com/retrieve/pii/S0140673600023515
HSL7884
Aitken M, Holt F.
Consumer choice or chaos?
Chemist and Druggist 2000 Jun 10; 253:34, 36
HSL8947
Balasubramaniam T
Background Information on Fourteen FDA Approved HIV/AIDS Drugs
Washington, DC: Consumer Project on Technology 2000 Jun 8
http://www.cptech.org/ip/health/aids/druginfo.html
HSL216
Moynihan R, Bero L, Ross-Degnan D, Henry D, Lee K, Watkins J, Mah C, Soumerai SB.
Coverage by the news media of the benefits and risks of medications.
N Engl J Med 2000 Jun 1; 342:(22):1645-50
http://content.nejm.org/cgi/content/full/342/22/1645
HSL230
Chard JA, Tallon D, Dieppe P.
Epidemiology of research into interventions for the treatment of osteoarthritis of the knee joint
Annals of the Rheumatic Diseases 2000 Jun; 59:414-418
http://ard.bmjjournals.com/cgi/content/full/59/6/414
HSL1856
Mehta PN.
Drugmakers and continuing medical education.
Indian Pediatr 2000 Jun; 37:(6):626-30
HSL3703
Researched Medicines Industry (RMI).
Direct to consumer advertising can enhance public health. The case for direct-to-consumer prescription medicine advertising.
Wellington NZ: Researched Medicines Industry (RMI). 2000 Jun
HSL4601
D'Arcy PF, Hadden DR.
Are drug proprietary names necessary?
Adverse Drug React Toxicol Rev 2000 Jun; 19:(2):117-21
HSL1686
Wazana A.
Gifts to physicians from the pharmaceutical industry
JAMA 2000 May 24; 283:(20):2655-8
HSL2579
Wazana A.
Gifts to physicians from the pharmaceutical industry [1st of 2 replies]
JAMA 2000 May 24-31; 283:(20):2675
HSL2631
McKinney WP.
Gifts to physicians from the pharmaceutical industry [4th of 4 letters]
JAMA 2000 May 24-31; 283:(20):2656-7
HSL6938
Edwards DA.
Gifts to physicians from the pharmaceutical industry.
JAMA 2000 May 24-31; 283:(20):2656
HSL6939
Howard SM.
Gifts to physicians from the pharmaceutical industry.
JAMA 2000 May 24-31; 283:(20):2655-6
HSL6940
McKinney WP, Rich EC.
Gifts to physicians from the pharmaceutical industry.
JAMA 2000 May 24-31; 283:(20):2656-7
HSL6941
Vollman J.
Gifts to physicians from the pharmaceutical industry [3rd of 4 letters]
JAMA 2000 May 24-31; 283:(20):2656
HSL231
Bodenheimer T.
Uneasy alliance--clinical investigators and the pharmaceutical industry.
N Engl J Med 2000 May 18; 342:(20):1539-44
http://content.nejm.org/cgi/content/extract/342/20/1539
HSL234
Angell M.
Is academic medicine for sale?
N Engl J Med 2000 May 18; 342:(20):1516-8
http://content.nejm.org/cgi/content/extract/342/20/1516
HSL8949
Office of the Chairman
The Benefits of Medical Research and the Role of the NIH
Washington, DC: US Senate 2000 May 17
http://hsc.utoledo.edu/research/nih_research_benefits.pdf
HSL856
Irwig LM, Loy CT, Chapman S, Glasziou PP, Mansfield PR, Salkeld GP, Walton MM.
!nform test kits distributed with the MJA.
Med J Aust 2000 May 15; 172:(10):518-9
HSL7917
Starr CH.
When drug names spell trouble
Drug Topics 2000 May 15; 144:49-50, 53-54, 57-58
HSL6937
MacKay P.
Pharmaceutical advertising - as seen on TV
New Zealand Association Newsletter 2000 May 121-2
HSL20113
MacKinven M
Drug makers risking penalties over promos
New Zealand Doctor 2000 May 1015
HSL2578
Weatherall D.
Academia and industry: increasingly uneasy bedfellows.
Lancet 2000 May 6; 355:(9215):1574
http://linkinghub.elsevier.com/retrieve/pii/S014067360002211X
HSL20137
Moodie P
Feeling blue? Have we got the drug for you!
New Zealand GP 2000 May 310
HSL2285
Sackett DL.
Why randomized controlled trials fail but needn't: 1. Failure to gain "coal-face" commitment and to use the uncertainty principle.
CMAJ 2000 May 2; 162:(9):1311-4
http://www.cmaj.ca/cgi/content/full/162/9/1311
HSL7947
Swartwood DE.
Ethics and managed care formularies.
Am J Health Syst Pharm 2000 May 1; 57:(9):851
http://www.ajhp.org/
HSL7952
McAllister JC.
Fortresses and formularies: response 3
American Journal of Health System Pharmacy 2000 May 1; 57:859-860
HSL6936
Kollek D.
How advertisements have changed
Canadian Family Physician 2000 May; 46:1025-1026
HSL7822
Cooper W.
Drug wars, episode two: health plans strike back
Pharmaceutical Executive 2000 May; 110, 112, 114
HSL7826
Wechsler J.
Congressional concerns
Pharmaceutical Executive 2000 May; 20:22, 24, 26, 28
HSL7851
Smeaton J.
To market, to market
Australian Journal of Pharmacy 2000 May; 81:470-471
HSL19542
Pomper S
Drug Rush: Why the Prescription Drug Market is Unsafe at High Speeds
Washington Monthly 2000 May
http://www.washingtonmonthly.com/features/2000/0005.pomper.html
HSL20139
Jeffries M
The mark of Zorro
Pharmaceutical Marketing 2000 May;
HSL18016
Mann RD, Pearce GL, Dunn N, Shakir S.
Sedation with 'non-sedating' antihistamines: four prescription-event monitoring studies in general practice - Commentary: Reporting of adverse events is worth the effort
BMJ 2000 Apr 29; 320:(7243):1184-6
http://www.bmj.com/cgi/content/full/320/7243/1184?view=long&pmid=10784544
HSL19543
Gerth J, Stolberg SG
Drug Companies Profit From Research Supported by Taxpayers
The New York Times 2000 Apr 23
http://partners.nytimes.com/library/national/science/health/042300hth-drugs.html
HSL19544
Mullins CD, Palumbo F, Stuart B,
The Impact of Pipeline Drugs on Pharmaceutical Spending
Center on Drugs and Public Policy University of Maryland School of Pharmacy 2000 Apr 13
www.ahipresearch.org/PDFs/25_ExecSumImpactofPipelineDrugs.pdf
HSL19545
Henney J
The Drug Industry’s Performance In Finishing Postmarketing Research (Phase IV) Studies
Public Citizen 2000 Apr 13
http://www.citizen.org/hrg1520
HSL7931
Gebhart F.
They shoot! They score! Rx scoreboard
Drug Topics 2000 Apr 3; 144:31-32, 35-36, 39
Page 141 of 143 pages ‹ First < 139 140 141 142 143 >
